Treatment of human Jurkat cells with staurosporine activates caspases to promote the apoptotic program. One of the caspases activated during apoptosis is caspase 3, which cleaves ICAD at residues Asp117 and Asp224 [3, 9] . This cleavage allows the release of CAD from ICAD, and CAD then cleaves chromosomal DNA. Replacement of the aspartic acid residues by glutamic acid renders ICAD resistant to caspases without affecting its ability to inhibit the DNase activity of CAD [3] .
Treatment of human Jurkat cells with staurosporine activates caspases to promote the apoptotic program. One of the caspases activated during apoptosis is caspase 3, which cleaves ICAD at residues Asp117 and Asp224 [3, 9] . This cleavage allows the release of CAD from ICAD, and CAD then cleaves chromosomal DNA. Replacement of the aspartic acid residues by glutamic acid renders ICAD resistant to caspases without affecting its ability to inhibit the DNase activity of CAD [3] .
We have previously established Jurkat cell transformants (JILdm) that express a mutant form of mouse ICAD, which carries glutamic acid in place of residues Asp117 and Asp224 [3, 9] . When Jurkat cells and JILdm cells were treated with 10 µM staurosporine, both cell lines died quickly and more than 80% of cells became Annexin-Vpositive within 2 hours ( [3] ; data not shown). As shown in Figure 1a , the chromosomal DNA of Jurkat cells quickly underwent extensive fragmentation. Most of the chromosomal DNA degraded into nucleosomal units within 2 hours. This process was caspase-dependent because preincubation of Jurkat cells with a broad caspase inhibitor, zVAD-fmk, completely prevented the DNA fragmentation. In contrast, JILdm cells expressing the caspase-resistant ICAD were resistant to the staurosporine-induced DNA fragmentation. Western-blot analysis indicated that the endogenous ICAD in Jurkat and JILdm cells was cleaved within 2 hours, whereas the mutant ICAD in JILdm cells remained intact for at least 3 hours (data not shown). Large-scale chromatin fragmentation is known to precede the nucleosomal fragmentation of chromosomal DNA during apoptosis [10, 11] . To examine whether CAD is involved in the large-scale chromatin fragmentation, chromosomal DNA in Jurkat and JILdm cells was analyzed by pulse-field gel electrophoresis. As shown in Figure 1b , the chromosomal DNA of Jurkat cells degraded within 1 hour, showing broad smearing bands with a peak at about 50 kb. The DNA fragments became smaller as Jurkat cells were incubated for longer periods of time with staurosporine. This large-scale chromatin degradation was not observed if the cells were pre-incubated with z-VAD-fmk. In contrast, treatment of JILdm cells with staurosporine did not cause large-scale chromatin degradation and the chromosomal DNA remained intact.
The morphology of the dying cells was then observed by electron microscopy. As shown in Figure 2a , when Jurkat cells were treated with staurosporine, chromatin condensed near the nuclear periphery within 1 hour. The condensed chromatin was fragmented at later time points and after a 3 hour incubation with staurosporine, all cells carried the fragmented and condensed nuclei. If the cells were pre-incubated with the caspase inhibitor, staurosporine caused a slight change in nuclear morphology but no condensation and fragmentation of nuclei was observed ( Figure 2e ). Staurosporine also induced morphological changes of nuclei in JILdm cells. As shown in Figure 2g , the chromatin of JILdm cells condensed near the nuclear periphery within 1 hour. A difference from that observed in Jurkat cells was that the condensed chromatin in JILdm cells remained near the nuclear periphery and no clear fragmentation of the condensed nuclei occurred even after a 3 hour incubation with staurosporine ( Figure 2i ). The condensation of nuclei in JILdm cells was also blocked by a caspase inhibitor (Figure 2j ).
In this report, we have shown that the staurosporineinduced large-scale chromatin fragmentation, as well as the nucleosomal DNA fragmentation, depends on caspase activation and can be inhibited by ICAD. These results suggest that both large-scale chromatin fragmentation and nucleosomal DNA fragmentation are caused by an ICADinhibitable DNase, probably CAD. Chromatin periodically attaches to the nuclear scaffold to form a series of 30-50 kb loops [12] . Given that the scaffold-attachment regions are more sensitive to nuclease than other regions [13] , the activated CAD first cleaves DNA at this point and produces large-scale chromatin fragmentation. This unpacks the chromatin structure and CAD gains access to nucleosomes and causes nucleosomal DNA fragmentation. Susin et al. [14] recently identified AIF (apoptosis-inducing factor), which is released from mitochondria. AIF was proposed to enter nuclei to activate a DNase(s) that causes large-scale chromatin fragmentation but not nucleosomal fragmentation in a caspase-independent manner. Although it is very difficult to integrate these results into our model, our results indicate that the DNase activated by AIF should be inhibitable by ICAD.
We have shown that the apoptotic chromatin condensation could occur without any DNA fragmentation. This was also observed with Fas-induced apoptosis in Fas-expressing murine WR19L cells: treatment of the cells expressing the non-cleavable ICAD mutant with agonistic anti-Fas antibody caused nuclear morphological changes but not DNA fragmentation. Recently, Liu et al. [5] reported that CAD is responsible not only for DNA fragmentation but also for the morphological changes in nuclei. We also observed a similar result using a cell-free system -when isolated nuclei were incubated with purified CAD, the chromosomal DNA was degraded and nuclei condensed and fragmented (unpublished observations). We might thus conclude that two different pathways can lead to nuclear morphological changes during apoptosis, one caused by CAD-induced DNA fragmentation and another that does not involve DNA degradation. The staurosporine-induced morphological changes of nuclei were inhibited by a caspase inhibitor, suggesting that the other factor(s) responsible for the chromatin condensation is a caspase or a molecule downstream of the caspase cascade. Caspase 6 is known to cleave nuclear lamins and its involvement in nuclear morphological changes has been suggested [15] . Incubation of nuclei with caspase 6 or with a cocktail containing eight different caspases (caspases 1-8), however, did not cause morphological changes (data not shown). On the other hand, Samejima et al. [16] prepared apoptotic extracts from chicken DU249 cells and found an activity that causes morphological changes in nuclei. This activity was inhibited by caspase inhibitors but not by ICAD. This finding agrees with ours and indicates that there is a factor(s) distinct from CAD or caspases that is responsible for nuclear morphological changes during apoptosis. Purification and characterization of this factor will be necessary to understand the mechanism and physiological roles of the nuclear morphological changes that accompany apoptosis.
Materials and methods

Assays for cell death and DNA fragmentation
Jurkat cells or transformants (JILdm) (2.5 × 10 5 cells/ml) expressing caspase-resistant ICAD-L mutant were incubated at 37°C for various periods of time with 10 µM staurosporine and cell death was assayed by the WST-1 or Annexin V method, as described previously [3] . To analyze the nucleosomal DNA fragmentation, 2.5 × 10 5 cells were lysed by incubating at 37°C overnight with 0.2 mg/ml proteinase K in 500 µl of 100 mM Tris-HCl pH 8.5, 5 mM EDTA, 200 mM NaCl and 0.2% SDS. DNA was then precipitated with isopropanol, treated with 0.1 mg/ml RNase A, and analyzed on a 1.5% agarose gel in 1 × TBE buffer.
Pulse-field gel electrophoresis
The pulse-field gel electrophoresis was carried out with Gene Navigator from Amersham-Pharmacia (Piscataway) according to the instructions provided by the supplier. In brief, 1 × 10 6 cells were suspended in 50 µl of ice-cold buffer A (10 mM Tris-HCl pH 8.0, 100 mM EDTA and 20 mM NaCl). The cell suspension was mixed with an equal volume of 1% low-melting point agarose (Amersham-Pharmacia) in buffer A, transferred to wells of agarose blockformers and set at 4°C for 15 min. Agarose blocks were removed form the blockformer and incubated twice at 50°C for 24 h in 2 ml buffer A containing 1 mg/ml proteinase K and 1% sarkosyl with gentle shaking. The blocks were then incubated twice at 50°C for 1 h in 2 ml stop buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA and 40 µg/ml PMSF). After washing with TE at 4°C, the blocks were inserted into wells of a 1% agarose gel in 0.5 × TBE. Electrophoresis was carried out at 200 V for 20 h with a 1-30 sec pulse time using the interpolation mode.
Electron microscopy
Cells were fixed with 2% glutaraldehyde, 2% paraformaldehyde in phosphate-buffered saline for 2 h and post-fixed with 2% OsO 4 for 1 h. After block-staining with a 2% aqueous solution of uranyl acetate they were dehydrated with ethanol in a graded series of concentrations and embedded in Epon 812. Thin sections of the cells were prepared using an ultramicrotome (Richert Ultracut N, Nissei); these were stained with lead citrate and uranyl acetate and observed with a Hitachi H-7100 electron transmission microscope. 
